ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Daniel Hayes Elected President of ASCO

December 12, 2014

Neurocognitive Deficits Affect Future Adult Employment

September 30, 2011

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians

May 29, 1992

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013